Healthpeak Properties (NYSE:DOC) Announces Quarterly Earnings Results

Healthpeak Properties (NYSE:DOC) posted its quarterly earnings data on Thursday. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23), Zacks reports. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.69%. The business had revenue of $695.50 million during the quarter, compared to analysts’ expectations of $665.11 million. During the same quarter last year, the firm earned $0.45 earnings per share. The firm’s quarterly revenue was up 27.5% compared to the same quarter last year. Healthpeak Properties updated its FY 2024 guidance to 1.770-1.810 EPS.

Healthpeak Properties Trading Up 5.5 %

NYSE:DOC traded up $1.14 during trading hours on Friday, reaching $21.90. 8,948,525 shares of the stock were exchanged, compared to its average volume of 3,874,896. Healthpeak Properties has a twelve month low of $15.24 and a twelve month high of $22.38. The business has a 50-day moving average of $19.81 and a two-hundred day moving average of $17.23. The company has a market capitalization of $15.41 billion, a price-to-earnings ratio of 62.57, a PEG ratio of 2.73 and a beta of 1.11. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.92.

Healthpeak Properties Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Monday, August 5th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.48%. The ex-dividend date is Monday, August 5th. Healthpeak Properties’s payout ratio is 342.87%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on DOC shares. Wedbush upgraded shares of Healthpeak Properties from a “neutral” rating to an “outperform” rating in a research report on Friday, May 3rd. Argus raised Healthpeak Properties to a “strong-buy” rating in a report on Thursday, May 9th. Scotiabank lifted their target price on shares of Healthpeak Properties from $22.00 to $23.00 and gave the stock a “sector outperform” rating in a research note on Thursday, May 16th. JPMorgan Chase & Co. increased their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, May 16th. Finally, Bank of America raised Healthpeak Properties from an “underperform” rating to a “buy” rating and increased their price target for the company from $18.00 to $25.00 in a report on Monday, April 1st. Six analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.90.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.